Plasma D-dimer concentrations in different clinical conditions

Acta Clinica Belgica

Volumn 57, Issue 6, 2002, Pages 325-330

  Ver Elst, K ^a   Jochmans, K ^a   De Pauw, A ^a   De Waele, M ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

D dimer; Hypercoagulable states; VIDAS

Indexed keywords

D DIMER; FIBRIN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CHILD; DEEP VEIN THROMBOSIS; FEMALE; FIBRINOLYSIS; HOSPITAL PATIENT; HUMAN; INFANT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREGNANCY; RETROSPECTIVE STUDY;

EID: 0036873982     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2002.060     Document Type: Article

References (29)

1. Francis CW, Marder VJ. A molecular model of plasmic degradation of crosslinked fibrin. Sem Thromb Haemost. 1982; 8: 25-35.
2. Pittet JL, de Moerloose P, Reber G, et al. VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma. Clin Chem. 1996; 42: 410-415.
3. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurements of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost. 1994; 71: 1-6.
4. Janssen MCH, Heebels AE, de Metz M, et al. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deen venous thrombosis. Thromb Haemost. 1997: 77: 262-6.
5. D'Angelo A, D'Alessandro G, Tomassini L, Pittet JL, Dupuy G, Crippa L. Evaluation of a new rapid quantitative D-dimer assay in patients with clinically suspected deep vein thrombosis. Thromb Haemost. 1996; 75: 412-6.
6. Freyburger G, Trillaud H, Labrouche S, et al. D-dimer strategy in thrombosis exclusion-A gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost. 1998; 79: 32-7.
7. De Moerloose P, Desmarais S, Bounameaux H, et al. Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism. Thromb Haemost. 1996; 75: 11-3.
8. Barro C, Bosson JL, Pernod G, Carpentier PH, Polack B. Plasma D-dimers: comparison of ELISA with a new, rapid, quantitative latex assay. Clin Lab Haem. 1999; 21: 363-4.
9. Keeling DM, Wright M, Baker P, Sackett D. D-dimer for the exclusion of venous thromboembolism: comparison of a new automated latex particle immunoassay (MDA D-dimer) with an established enzyme-linked fluorescent assay (VIDAS D-dimer). Clin Lab Haem. 1999; 21: 359-362.
10. Arnout J, Verhaeghe R, Vermylen J. Diagnostisch belang van de D-dimeer bepaling. Tijdschr. voor Geneeskunde. 1992; 48: 1085-7.
11. Raimondi P, Bongard O, de Moerloose P, Reber G, Waldwogel F, Bounameaux H. D-dimer plasma concentrations in various clinical conditions: implications for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res. 1993; 69: 125-30.
12. Siméon D, Petitot L, Martelet M, Mouallem J, Bombarde A. Apport actuel des D-dimères dans le diagnostic d'exclusion de la maladie thromboembolique veineuse. Immunoanal biol spéc. 1999; 14: 321-9.
13. Schafer AI. The hypercoagulable states. Ann Intern Med. 1985; 102: 814-28.
14. Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med. 1993; 119: 819-827.
15. Gabazza EC, Taguchi O, Yamakami T, et al. Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer. Cancer. 1992; 70(11): 2631-6.
16. Tomer A, Harker LA, Kasey S, Eckman JR. Thrombogenesis in sickle cell disease. J Lab Clin Med. 2001; 137: 398-407.
17. Dempfle CE, Kontny, Abildgaard U. Predictive value of coagulation markers concerning clinical outcome 90 days after anterior myocardial infarction. Thromb Haemost. 1999; 81(5): 701-4.
18. Lowe GDO, Yarnell WG, Rumley D, Sweetnam PM. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study. Are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol. 2001; 21: 603-10.
19. Danesh J, Whincup P, Walker M, et al. Fibrin D-dimer and coronary heart disease. Prospective study and meta-analysis. Circulation. 2001; 103: 2323-7.
20. Bayes-Genis A, Mateo J, Santalo M, et al. D-dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J. 2000; 140(3): 379-384.
21. Vukocich T, Teufelbauer H, Fritzer M, Kreuzer S, Knoflach P. Hemostasis activation in patients with liver cirrhosis. Thromb Res. 1995; 77(3): 271-8.
22. Dunn ID, Hui AC, Triffitt PD, et al. Plasma D-dimer as a marker for postoperative deep venous thrombosis. A study after total hip or knee arthroplasty. Thromb Haemost. 1994; 72(5): 663-5.
23. Salvioni A, Perego GB, Marenzi G, et al. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate. Eur Heart J. 1996; 17(2): 230-6.
24. Fon EA, Mackey A, Cote R, et al. Hemostatic markers in acute transient ischemic attacks. Stroke. 1994; 25(2):282-6.
25. Hager K, Platt D. Fibrin degeneration product concentrations (D-dimers) in the course of ageing. Gerontol. 1995; 41: 159-65.
26. Kario K, Matsuo T, Kobayashi H. Which factors affect high D-dimer levels in elderly? Thromb Res. 1991; 62: 501-8.
27. Cardoy Y, Pierrejean D, FontanB, Sié P, Bonen B. Influence of ageing on the activity of the hemostatic system: prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years. Nouv Rev Fr Hematol. 1992; 34: 43-6.
28. Schlit AF, Col-De Beys C, Moriau M, Lavenne-Pardonge E. Acquired activated protein C resistance in pregnancy. Thromb Res. 1996; 84: 203-6.
29. Nolan TE, Smith RP, Devroe LD. Maternal plasma D-dimer levels in normal and complicated pregnancies. Obstet Gynecol. 1993; 81(2): 235-8.